rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
1993-6-14
|
pubmed:abstractText |
Hospitalization and intravenous (IV) broad-spectrum antibiotics are the standard of care for all febrile neutropenic patients with cancer. Recent work suggests that a low-risk population exists who might benefit from an alternate approach.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
71
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
3640-6
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:8490912-Administration, Oral,
pubmed-meshheading:8490912-Adolescent,
pubmed-meshheading:8490912-Adult,
pubmed-meshheading:8490912-Aged,
pubmed-meshheading:8490912-Ambulatory Care,
pubmed-meshheading:8490912-Aztreonam,
pubmed-meshheading:8490912-Bacteremia,
pubmed-meshheading:8490912-Bacterial Infections,
pubmed-meshheading:8490912-Ciprofloxacin,
pubmed-meshheading:8490912-Clindamycin,
pubmed-meshheading:8490912-Female,
pubmed-meshheading:8490912-Fever,
pubmed-meshheading:8490912-Humans,
pubmed-meshheading:8490912-Injections, Intravenous,
pubmed-meshheading:8490912-Male,
pubmed-meshheading:8490912-Middle Aged,
pubmed-meshheading:8490912-Neoplasms,
pubmed-meshheading:8490912-Neutropenia,
pubmed-meshheading:8490912-Prospective Studies
|
pubmed:year |
1993
|
pubmed:articleTitle |
Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer.
|
pubmed:affiliation |
Department of Medical Specialties, University of Texas M.D. Anderson Cancer Center, Houston 77030.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|